Andrew Feilden, Smithers Rapra Ltd. - Qepler Summits And Conferences

Andrew Feilden

Technical director
Smithers Rapra Ltd.
Shawbury, United Kingdom
Industry-leading rubber and plastics expertise; materials testing, chemical analysis, expert support, conferences, training and market intelligence.

Dr. Andrew Feilden is the Technical Director at Smithers Rapra and Smithers Pira where he leads the technical aspects of the chemistry department.

Prior to that he was the Chemistry Operations Director, for 6 years, where he lead the chemistry group at the Shawbury site in the UK. The Shawbury site carries out extractable and leachable testing, GPC analysis and food contact testing. He has delivered numerous international podium presentations on Extractables and leachables.

Andrew has been with Smithers for over 7 years, prior to that he worked for AstraZeneca, specialising in Extractables and Leachables.

He has a degree and D Phil from the university of York, is a Fellow of the Royal Society of Chemistry and is a Scientific advisor to IPAC-RS

Related Sessions:

Inhaled Drug Delivery
Summit 2019

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 27 Feb 2019
  • Berlin, DE
  • Pharma
Day 2: Thursday, 28 February 2019
BLOCK: ANALYTICAL APPROACHES & SPECIFICATIONS.
CASE STUDY: Material selection for OINDPs (orally inhaled and nasal drug products).
  • Types of materials
  • Priorities for selecting materials
    • Physical vs chemical vs chemical vs change management
  • Risk Management for materials and components
View Details

Genotoxic Impurities in
Pharmaceuticals Summit 2019

GTI strategies & new methodologies: analysis, in silico & regulations. Challenges & opportunities.
  • 11 Apr 2019
  • Berlin, DE
  • Pharma
Day 1: Thursday, 11 April 2019
BLOCK:
CASE STUDY: ICH M7 and extractables & leachables: understanding control, analysis and regulations of E&L.
  • What are extractables and leachables
  • What are the similarities and differences between E and L and genotoxic impurities
  • What are the regulations that are applicable, specifically M7
View Details